Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-site Safety and Effectiveness Post-Approval Study of FARAPULSE Pulsed Field Ablation in Paroxysmal Atrial Fibrillation

NCT06431815 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT06431815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06431815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-site Safety and Effectiveness Post-Approval Study of FARAPULSE Pulsed Field Ablation in Paroxysmal Atrial Fibrillation
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Active, not recruiting
Start date
September 25, 2024
Completion date
October 31, 2029
Enrollment
228 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation